Clinical trial
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
NCT02943590 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 13, 2017
- Completion date
- October 11, 2023
- Enrollment
- 300 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.